IP Library Granted Patent US 10,383,636
Granted Patent B2
US 10,383,636 · App. 15/918,869 · Granted Aug 20, 2019

Embolization device and a method of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,383,636
App. No.
15/918,869
Granted
Aug 20, 2019
Kind
B2
Abstract

Non-expandable space-occupying devices for treating voids within the body are disclosed. The devices can have multiple non-expandable space-occupying elements connected to a flexible leader. Methods of making and using the devices are also disclosed.

Claims (37)

1. A system for treating an aneurysm comprising:

a catheter having a distal exit having a deployed configuration and an undeployed configuration; and

a self-fusing material,

wherein when the self-fusing material is in the undeployed configuration, the distal exit is placed between an outer surface of a prosthesis and a wall of the aneurysm, and the self-fusing material is in the catheter,

wherein when the self-fusing material is in a deployed configuration, the self-fusing material is in the space between the outer surface of the prosthesis and the wall of the aneurysm, and the self-fusing material has fused to itself, promoting a thrombogenic response within the aneurysm to stabilize the self-fusing material and the prosthesis,

wherein the self-fusing material is configured to promote fusing or other coagulative effect, and

wherein the self-fusing material is radiopaque such that in the deployed configuration, the visualization of the prosthesis is unobstructed by the radiopaque nature of the self-fusing material.

2. The system of claim 1 , wherein the self-fusing material comprises a polymer formulation.

3. The system of claim 1 , wherein at the distal exit of the catheter, the catheter comprises a valve to minimize or completely prevent backflow of body fluids or other leakage.

4. The system of claim 1 , further comprising a visualization tool for visualizing the self-fusing material before, during, and after the self-fusing material has been deployed.

5. The system of claim 1 , wherein the self-fusing material comprises a coating, wherein the coating is an agent, and wherein the agent is at least one of a therapeutic agent and a diagnostic agent.

6. A system for treating an aneurysm comprising:

a catheter having a distal exit having a deployed configuration and an undeployed configuration; and

a self-fusing material,

wherein when the self-fusing material is in an undeployed configuration, the distal exit is placed between an outer surface of a prosthesis and a wall of the aneurysm, and the self-fusing material is in the catheter,

wherein when the self-fusing material is in a deployed configuration, the self-fusing material is in the space of the aneurysm, and the self-fusing material has fused to itself, promoting a thrombogenic response within the aneurysm to stabilize the self-fusing material,

wherein the self-fusing material is configured to promote fusing or other coagulative effect, and

wherein at the distal exit of the catheter, the catheter comprises a valve to minimize or completely prevent backflow of body fluids or other leakage.

7. The system of claim 6 , wherein the self-fusing material comprises a polymer formulation.

8. The system of claim 6 , wherein at the distal exit of the catheter, the catheter comprises a valve to minimize or completely prevent backflow of body fluids or other leakage.

9. The system of claim 6 , further comprising a visualization tool that can visualize the self-fusing material before, during, and after the self-fusing material has been deployed.

10. A method for treating an aneurysm comprising:

placing a distal exit of a catheter between an outer surface of a prosthesis and a wall of the aneurysm; and

deploying a self-fusing material through the distal exit of the catheter;

wherein after the self-fusing material is fully deployed from the catheter, the self-fusing material fuses with itself, promoting a thrombogenic response within the aneurysm to stabilize the self-fusing material,

wherein the self-fusing material is configured to promote fusing or other coagulative effect, and

wherein the self-fusing material is radiopaque such that in the deployed configuration, the visualization of the prosthesis is unobstructed by the radiopaque nature of the self-fusing material.

11. The method of claim 10 , wherein the self-fusing material comprises a polymer formulation.

12. The method of claim 10 , wherein the self-fusing material is deployed within the space of the aneurysm using a trans-graft, trans-collateral, trans-sac, or endoluminal procedure.

13. The method of claim 10 , further comprising visualizing an initial placement and nesting of the self-fusing material prior to and during deployment with a visualization tool.

14. The method of claim 10 , wherein at the distal exit of the catheter, the catheter comprises a valve to minimize or completely prevent backflow of body fluids or other leakage.

15. The method of claim 10 , wherein placing the distal exit of the catheter between the outer surface of the prosthesis and the wall of the aneurysm comprises placing the distal exit of the catheter within a space of the aneurysm, wherein the space of the aneurysm is between the outer surface of the prosthesis and the wall of the aneurysm.

16. The method of claim 15 , wherein the self-fusing material is radiopaque such that after the self-fusing material has been deployed, the visualization of the prosthesis is unobstructed by the radiopaque nature of the self-fusing material.

17. The method of claim 15 , further comprising selecting the self-fusing material having a proper volume so that the self-fusing material is large enough to substantially fill a void in the aneurysm, yet small enough to prevent substantial alteration of a natural fluid flow through the prosthesis.

18. The method of claim 15 , wherein the self-fusing material is deployed between the outer surface of the prosthesis and the wall of the aneurysm using a trans-graft, trans-collateral, trans-sac, or endoluminal procedure.

19. The method of claim 15 , wherein the self-fusing material comprises a polymer formulation.

20. The method of claim 10 , further comprising visualizing the self-fusing material before, during, and after the self-fusing material has been deployed.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2022
From: FOGARTY, THOMAS J.
To: ENDOLOGIX LLC
Reel/Frame 058713/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2018
From: DREWS, MICHAEL J.; MODESITT, D. BRUCE; HOLMGREN, NEIL; WILLIS, DAVID B.
To: FOGARTY, THOMAS J.
Reel/Frame 045178/0940 →